BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares hit a new 52-week high during trading on Thursday . The stock traded as high as $1.63 and last traded at $1.51, with a volume of 46107 shares traded. The stock had previously closed at $1.54.
BioRestorative Therapies Stock Down 4.0 %
The company’s fifty day moving average is $1.63 and its 200 day moving average is $1.59. The firm has a market cap of $2.38 billion, a price-to-earnings ratio of -1.41 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Which Wall Street Analysts are the Most Accurate?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- The Role Economic Reports Play in a Successful Investment Strategy
- Time to Load Up on Home Builders?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
